ArticleOncotarget2015

Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.

Nelma Pertega-Gomes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.